Kyle Esplin - the trials and tribulations of the UK CBD industry

07/07/21 • 64 min

Kyle Esplin, a professional musician by trade, discovered CBD and hemp after becoming severely debilitated by post viral fatigue.
Where conventional medicine failed, CBD and hemp extracts gradually brought Kyle back to health, so he decided to harness his new found passion and create his own CBD brand, Holistic Highland Hemp.
A vocal challenger to regulations such as Novel Foods and the licensing of hemp farming through the home office, Kyle is chair of the Scottish Hemp Association and is in the process of making a documentary about the UK hemp industry.
Links
Holistic Highland Hemp
Scottish Hemp Association
Cannabis Industry Council

Support the show

Support the show

Previous Episode

Professor Javier Fernández Ruiz - cannabis research in neurodegenerative diseases

Professor Javier Fernández-Ruiz is Professor in the Department of Biochemistry and Molecular Biology, Faculty of Medicine at the Complutense University of Madrid. He is currently the Principal Investigator of the “Cannabinoids and Neurological Disorders” research group at the Complutense University. Professor Fernandez is also a member of the Editorial Board in the British Journal of Pharmacology.
He has authored several papers outlining the therapeutic potential of cannabinoids in degenerative disorders including:
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomes

Prospects for cannabinoid therapies in basal ganglia disorders
As Professor Fernandez mentioned in the podcast, he is happy to be contacted by anyone interested in finding out more about his area of research and can be emailed on [email protected]. (Please remember he is not a medical doctor).

Support the show

Next Episode

Project Twenty 21 - medical cannabis real world evidence

This week's episode is dedicated to Project Twenty21, the UK medical cannabis registry collecting data on safety and efficacy, while offering the participants subsidised medical cannabis prescriptions.
I speak to Anne Katrin Schlag, Head of Research at Drug Science, and overseeing the research side of T21. She explains how the project came about, what it aims to achieve, and what benefits there are for patients.
She also discusses some promising preliminary findings from T21 shared in a peer reviewed paper published earlier this year.
To get the patient's perspective I speak to Claire Bywalec, who developed fibromyalgia after a riding accident as a child.
Claire explains not only how cannabis has transformed her life, but also the process of onboarding with T21 and how it's worked for her.
For more information about getting involved with Project Twenty21, head to https://www.drugscience.org.uk/project-twenty21/

Support the show